Author Correction: From melanocytes to melanomas. Read more about Author Correction: From melanocytes to melanomas.
The duality of human oncoproteins: drivers of cancer and congenital disorders. Read more about The duality of human oncoproteins: drivers of cancer and congenital disorders.
A framework for advancing our understanding of cancer-associated fibroblasts. Read more about A framework for advancing our understanding of cancer-associated fibroblasts.
An analysis of genetic heterogeneity in untreated cancers. Read more about An analysis of genetic heterogeneity in untreated cancers.
A model for RAS mutation patterns in cancers: finding the sweet spot. Read more about A model for RAS mutation patterns in cancers: finding the sweet spot.
Clinical tumour sequencing for precision oncology: time for a universal strategy. Read more about Clinical tumour sequencing for precision oncology: time for a universal strategy.
Understanding and targeting resistance mechanisms in NSCLC. Read more about Understanding and targeting resistance mechanisms in NSCLC.
Drugging the 'undruggable' cancer targets. Read more about Drugging the 'undruggable' cancer targets.
New frontiers in translational control of the cancer genome. Read more about New frontiers in translational control of the cancer genome.
